Table 2.
Ref. | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
Type 1: Spontaneous MI | |||||||
Aldous et al[12] | + | ? | - | + | + | ? | - |
Aldous et al[13] | + | + | + | + | + | ? | ? |
al-Harbi et al[14] | + | ? | + | + | + | ? | ? |
Apple et al[15] | + | + | + | + | + | ? | ? |
Bahrmann et al[16] | + | + | - | + | - | ? | + |
Bertinchant et al[17] | + | + | + | + | + | ? | ? |
Biener et al[18] | + | + | + | + | + | ? | ? |
Bjurman et al[19] | + | + | ? | + | + | - | ? |
de Winter et al[20] | + | - | + | + | + | ? | + |
Falahati et al[21] | + | + | ? | + | + | ? | ? |
Haaf et al[22] | + | + | - | + | + | ? | + |
Lucia et al[23] | + | - | ? | + | + | ? | ? |
Mohler et al[24] | + | + | + | + | + | ? | ? |
Mueller et al[25] | + | + | + | + | + | ? | ? |
Reichlin et al[26] | + | + | - | + | + | ? | ? |
Reichlin et al[27] | + | + | + | + | + | + | + |
Wu[28] | + | + | + | + | + | ? | ? |
Successful reperfusion during acute MI | |||||||
Abe et al[29] | - | + | - | + | - | ? | - |
Apple et al[30] | ? | ? | - | ? | ? | ? | ? |
Ferraro et al[9] | - | ? | + | + | - | - | ? |
Ferraro et al[31] | + | - | ? | + | + | ? | ? |
Mair et al[32] | + | + | + | + | + | ? | - |
Ricchiuti et al[33] | + | + | + | + | ? | ? | ? |
Tanasijevic et al[34] | ? | ? | ? | - | ? | - | ? |
Tanasijevic et al[35] | - | - | - | ? | - | + | ? |
Type 4: MI associated with percutaneous coronary intervention | |||||||
Reimers et al[36] | - | + | + | + | ? | ? | ? |
Type 5: MI associated with coronary artery bypass grafting | |||||||
Abdel Aziz et al[37] | + | - | + | + | - | ? | ? |
Alyanakian et al[38] | + | + | + | + | - | ? | ? |
Benoit et al[39] | + | + | + | + | - | ? | ? |
Fellahi et al[40] | + | - | + | + | - | ? | + |
Katus et al[41] | + | - | + | + | - | ? | ? |
Lim et al[42] | + | + | + | + | - | + | + |
Mair et al[43] | - | + | + | + | + | ? | ? |
Thielmann et al[44] | + | + | + | + | + | ? | ? |
Thielmann et al[45] | + | + | + | + | + | ? | ? |
MI: Myocardial infarction. 1: Representativeness of the spectrum; 2: Acceptable reference standard; 3: Acceptable delay between tests; 4: Partial verification avoided; 5: Relevant clinical; 6: Uninterpretable results reported; 7: Withdrawals explained information.